Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 8/20 | 0.68 |
| ▸ | HPGD | P15428 | 1/20 | 0.68 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.63 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.63 |
| ▸ | NAAA | Q02083 | 1/20 | 0.53 |
| ▸ | TP53 | P04637 | 3/20 | 0.52 |
| ▸ | HIF1A | Q16665 | 3/20 | 0.52 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.52 |
| ▸ | THRB | P10828 | 2/20 | 0.47 |
| ▸ | ATM | Q13315 | 1/20 | 0.45 |
| ▸ | HCAR2 | Q8TDS4 | 3/20 | 0.40 |
| ▸ | HTT | P42858 | 1/20 | 0.40 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.38 |
| ▸ | DGKA | P23743 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
| ▸ | RAB9A | P51151 | 1/20 | 0.35 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13777750 | 0.96 | TSHR (0.69) | TSHRHPGDALDH1A1CYP3A4NAAA | |
| SCHEMBL12777812 | 0.94 | TSHR (0.61) | TSHRHPGDALDH1A1CYP3A4NAAA | |
| SCHEMBL13446682 | 0.94 | TSHR (0.73) | TSHRHPGDALDH1A1CYP3A4NAAA | |
| SCHEMBL11682363 | 0.92 | TSHR (0.61) | TSHRHPGDALDH1A1CYP3A4NAAA | |
| SCHEMBL15695739 | 0.91 | TSHR (0.63) | TSHRHPGDALDH1A1CYP3A4NAAA | |
| SCHEMBL18232150 | 0.91 | TSHR (0.63) | TSHRHPGDALDH1A1CYP3A4NAAA | |
| SCHEMBL10099803 | 0.86 | TSHR (0.73) | TSHRHPGDALDH1A1CYP3A4NAAA | |
| SCHEMBL14550291 | 0.86 | TSHR (0.73) | TSHRHPGDALDH1A1CYP3A4NAAA | |
| SCHEMBL4747317 | 0.86 | TSHR (0.61) | TSHRHPGDALDH1A1CYP3A4NAAA | |
| SCHEMBL321925 | 0.85 | TSHR (0.85) | TSHRHPGDALDH1A1CYP3A4TP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-107325217-A | A kind of method for preparing aqueous solid styrene-acrylic resin | 博立尔化工（扬州）有限公司 | 2017-11-07 | — | — | CN | disclosed |
| US-9802984-B2 | Biomimetic peptide and biodegradable delivery platform for the treatment of angiogenesis- and lymphangiogenesis-dependent diseases | THE JOHNS HOPKINS UNIVERSITY (US) | 2017-10-31 | — | — | US | disclosed |
| US-20160122390-A1 | A BIOMIMETIC PEPTIDE AND BIODEGRADABLE DELIVERY PLATFORM FOR THE TREATMENT OF ANGIOGENESIS- AND LYMPHANGIOGENESIS-DEPENDENT DISEASES | THE JOHNS HOPKINS UNIVERSITY (US) | 2016-05-05 | — | — | US | disclosed |
| US-20090189120-A1 | COMPOUND, LIQUID CRYSTAL COMPOSITION, AND ANISOTROPIC MATERIAL | FUJIFILM CORPORATION (JP) | 2009-07-30 | — | — | US | disclosed |
| CN-1266544-C | Photosnesitive resin composition comprising quinonediazide sulfate ester compound | DONGJIN SEMICHEM CO LTD (KR) | 2006-07-26 | — | — | CN | disclosed |
| CN-1568444-A | Photosnesitive resin composition comprising quinonediazide sulfate ester compound | DONGJIN SEMICHEM CO LTD (KR) | 2005-01-19 | — | — | CN | disclosed |
| EP-0000658-B1 | PROCESS FOR PREPARING ETHYLENICALLY UNSATURATED ISOCYANURATES | ICI AMERICAS INC. (US) | 1981-09-02 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160122390-A1 | A BIOMIMETIC PEPTIDE AND BIODEGRADABLE DELIVERY PLATFORM FOR THE TREATMENT OF ANGIOGENESIS- AND LYMPHANGIOGENESIS-DEPENDENT DISEASES | VEGFA, LRRFIP1, FLT1 | TSHR 2524/4885HPGD 3420/4885ALDH1A1 3688/4885 |
| US-20090189120-A1 | COMPOUND, LIQUID CRYSTAL COMPOSITION, AND ANISOTROPIC MATERIAL | CCNA2, CCNA1, CCNB2 | TSHR 3557/4885HPGD 4235/4885ALDH1A1 2881/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.